# Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis

> **NCT02553473** · PHASE3 · COMPLETED · sponsor: **Sorlandet Hospital HF** · enrollment: 121 (actual)

## Conditions studied

- Neuroborreliosis, Borrelia Burgdorferi

## Interventions

- **DRUG:** Doxycycline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02553473
- **Lead sponsor:** Sorlandet Hospital HF
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2020-01
- **Final completion:** 2021-02
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02553473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02553473, "Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02553473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*